Sun Pharma secures High Court injunction against Meghmani Lifesciences over trademark infringement. Court finds 'Esiraft' similar to...
pharma manufacturing
Project Dhadkan in Chhattisgarh screens children for congenital heart defects, providing free surgeries. Early detection is crucial...
Sun Pharma plans a $12B bid for Organon, potentially the largest overseas pharma acquisition by an Indian...
India allocates LPG for polymer, steel, and pharma sectors to boost industrial output during energy supply challenges....
US considers up to 100% tariffs on brand-name drugs, potentially impacting pharmaceutical investments, costs, and market access....
Biocon expands US portfolio with Bosaya & Aukelso biosimilars, offering affordable treatments for bone conditions. FDA-approved, now...
UPSIDA and JNPA partner to transform Lalitpur Pharma Park into a global export hub, streamlining logistics and...
Indian pharma exports approach $29 billion despite global volatility, highlighting India's role as a key affordable medicine...
Trump's tariff threat on pharma firms sparks debate. Impact on market access, investment strategies, and drug pricing....
US tariffs on patented drugs unlikely to significantly affect India's generic medicine exports. GTRI report highlights limited...